Trump's tariff move spurs RBC's second S&P 500 downgrade this year as macro stress builds across equity markets ...

RBC Capital initiated coverage of BeiGene (ONC) with an Outperform rating and $312 price target RBC sees a path to robust revenue growth driven by ...

RBC cuts its 2025 S&P target by 11% to 5,550, seeing a growth scare rising amid Trump tariffs. Read more here.

RBC Capital lowered the firm’s price target on Bausch Health (BHC) to $8.50 from $9 and keeps a Sector Perform rating on the shares. The firm ...

RBC Capital analyst Maurice Choy maintained a Hold rating on Fortis (FTS – Research Report) yesterday and set a price target of C$69.00. The ...

RBC Capital Markets on Thursday reshuffled its defense sector outlook, upgrading Northrop Grumman (NYSE:NOC) to Outperform ...

The firm's latest additions, including two brothers, bolster its employee advisor business in Scottsdale, Arizona.

RBC Capital keeps an Outperform rating and a $28 price target on Bloom Energy (BE) but notes that the company’s 6 MW ...

Investors anticipate strategic shift towards Europe, higher-margin businesses US accounts for 26% of RBC's revenue Since ...

Investment bank RBC Capital is calling for gold to extend its bull run to US$3,195 an ounce in 2026 as the safe-haven asset ...

Investing.com -- RBC Capital Markets analysts see a "compelling" buying opportunity in shares of SSE (LON: SSE ), citing the ...

March 26 (Reuters) - Barclays on Wednesday became the latest brokerage after Goldman Sachs and RBC Capital Markets to slash its year-end target for the benchmark S&P 500 index, due to uncertainty ...